Live
- BJP MP candidate Bharat Prasad visited the student who tried to commit suicide
- PM’s popularity in the fast lane: Autos with 'Har Dil Mein Modi' slogan spotted across Delhi
- Delhi-based political parties are like East India Company: Sukhbir Badal
- Golf: Diksha moves into Top-20 at South African Women’s Open
- KCR lashes out against BJP and Congress for destroying Telangana
- Dairy Science students visited the Milk cooling plant
- Moody feels Pant ahead in keepers’ race for T20 WC squad; Srikkanth picks Rahul over Samson as reserve keeper
- Thanking voters for extending 'unparalleled support' to NDA, PM Modi says second phase 'too good'
- Natural Relief for Menstrual Cramps: Beetroot Juice Recipe
- Asha Worker died in a road accident
Dr Reddys to spend up to $300 million on R&D
Dr Reddys Laboratories is planning to spend up to$300 million on research and development (R&D) during this financial year, a senior official of the company has said.
Hyderabad: Dr Reddys Laboratories is planning to spend up to$300 million on research and development (R&D) during this financial year, a senior official of the company has said.
President, CFO and global head (HR) of Dr Reddy's Saumen Chakraborty, during an 'earnings call', said the drug- maker spent $226 million during the last fiscal against $264 million in FY18.
The R&D spend for the quarter (January-March FY19) is Rs 366 crore, that is $53 million and EBIT 9.19 per cent of the sales for the quarter, he said.
The spend is lowered by 16 per cent year-on-year and is flat on a sequential quarter basis. The spend for FY19 is Rs 1,551 crore. That is $226 million as against $264 million in FY18,Chakraborty said.
"We expect the overall R&D for FY20 would be in the range of $250 million to $300 million," he said replying to a query.
The company would continue to focus on R&D for some interesting pipeline of proprietary products.
But, on an overall basis, the R&D spend would be lower in proprietary products when compared to previous year, he further said.
Speaking at the meeting, COO Erez Israeli said, "Now that we made the R&D organisation more efficient andcould handle more products with less cost, we want to continue with this plan of productivity to increase the R&D.
